Comparing Lantus vs Linagliptin
| Lantus (insulin glargine) | Linagliptin |
|
|---|
| Lantus (insulin glargine) | Linagliptin |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Lantus is a long-acting insulin that only needs to be injected once a day, subcutaneously. It is available as a prefilled pen (Lantus Solostar) or a 10mL vial. Hypoglycemia is the most common side... View more |
Prescription only
Prescribed for Type 2 Diabetes. Linagliptin may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||
| More about Lantus (insulin glargine) | More about Linagliptin | ||||||||
| Ratings & Reviews | |||||||||
|
Lantus has an average rating of 6.5 out of 10 from a total of 41 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 29% reported a negative effect. |
Linagliptin has an average rating of 3.9 out of 10 from a total of 81 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 63% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Lantus side effects |
View all Linagliptin side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Lantus prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other insulin glargine brands include: Basaglar, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar | Tradjenta | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
24 hours |
12 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 394 drugs are known to interact with Lantus:
|
A total of 349 drugs are known to interact with Linagliptin:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
April 20, 2000 |
May 02, 2011 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Humalog
Humalog (insulin lispro) is used to treat type 1 (insulin-dependent) diabetes in adults. Includes ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.